Incentives to improve corporate value through paid stock options
First written in FY2023-Q2. 1 of 3 entries say "Advanced", first in FY2025-H1. Latest entry: FY2025.
- FY2025ReframedAnnual report
「Eighth Series of Stock Acquisition Rights Common shares: 2,500,000 Ninth Series of Stock Acquisition Rights Common shares: 3,364,400 Decrease due to waiver: 3,364,400」
All of the Ninth Series of Stock Acquisition Rights lapsed following their waiver, leaving only the equivalent of 2,500,000 common shares under the Eighth Series of Stock Acquisition Rights outstanding at year-end. - FY2025-H1AdvancedAnnual report
「Resolution date 21 November 2024……Number of stock acquisition rights 33,644……Class, details and number of shares underlying the stock acquisition rights Common shares 3,364,400 shares……②If cumulative net sales for the fiscal year ending October 2025 are ¥10 billion or more.」
For the Ninth Series of Stock Acquisition Rights allocated on 9 December 2024, 33,644 rights, representing 3,364,400 potential shares, were issued, with an exercise price condition of a share price of at least ¥1,000 and cumulative net sales of at least ¥10 billion for the fiscal year ending October 2025. - FY2023-Q2First statedAnnual report
「We believe it is necessary to increase motivation and morale toward achieving performance targets and enhancing corporate value. These stock acquisition rights are being allotted to directors and employees of the company, officers of its subsidiaries and external collaborators as of the allotment date for the purpose of providing incentives.」
On 1 May 2023, 194,800 paid stock options, representing 19,480,000 potential shares, were granted through a third-party allotment. The recipients were officers, employees, officers of subsidiaries and external collaborators, and the purpose was to provide incentives to achieve performance targets and enhance corporate value.